ATRCAtriCure, Inc.
26.72USD-3.80%Mkt Cap: 1.35B USDP/E: Last update: 2026-06-01

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to …

Indicators:|

Key Statistics

Company
Market Cap1.35B USD
Enterprise Value1.33B USD
Revenue (TTM)552.16M USD
Gross Profit400.78M USD
Net Income (TTM)-11.45M USD
Revenue/Share11.51 USD
Last Price26.72 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)79.35
PEG10.00
EV/EBITDA74.92
EV/Revenue2.41
P/S2.54
P/B2.85
EPS (TTM)-0.10
EPS (Forward)0.35
52W Range
25.527% of range43.18
52W High43.18 USD
52W Low25.52 USD
Profitability
Gross Margin74.98%
Oper. Margin0.37%
EBITDA Margin3.21%
Profit Margin-2.14%
ROE-2.33%
ROA-1.75%
Growth
Revenue Growth14.30%
Earnings Growth
Cash Flow & Leverage
Operating CF57.33M USD
CapEx (TTM)15.05M USD
FCF Margin7.44%
FCF Yield3.04%
Net Debt-71.25M USD
Net Debt/EBITDA-4.01
Balance Sheet
Debt/Equity0.15
Current Ratio4.29
Quick Ratio2.97
Book Value/Sh9.711 USD
Cash/Share2.886 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)47.00 USD
Target Range36.00 USD55.00 USD
# Analysts8
Ownership
Shares Out.50.64M
Float48.55M
Insiders3.85%
Institutions102.35%
Short Interest
Short Ratio5.0d
Short % Float9.11%
Short % Out.8.75%
Shares Short4.43M
Short (prev mo.)3.61M
Technical
SMA 5028.50 (-6.2%)
SMA 20034.12 (-21.7%)
Beta1.28
S&P 52W Chg27.94%
Avg Vol (30d)822.47K
Avg Vol (10d)863.39K
Technical Indicators
RSI (14)46.6
MACD-0.0982
MACD Signal-0.1542
MACD Hist.+0.0561
BB Upper29.95 USD
BB Middle28.06 USD
BB Lower26.17 USD
BB Width13.48%
ATR (14)1.311 USD
Vol Ratio (20d)0.34x